Wirkstoffe & Arzneimittelsicherheit

Nebenwirkungen · Adjupanrix (previously Pandemic influenza vaccine (H5N1) (split virion, inactivated, adjuvanted) GlaxoSmithKline Biologicals)

Adjupanrix suspension and emulsion for emulsion for injection. Pandemic influenza vaccine (H5N1) (split virion, inactivated, adjuvanted) · Abschnitt 4.8 · PDF-Seite 7

HOS-212711 · Präparat HOS-154960

System Organ Frequency Adverse reactions Class 3 to < 6 (years) 6 to < 18 (years) Metabolism and Very common Uncommon Decreased appetite nutrition disorders Psychiatric Very common Uncommon Irritability/Fussiness disorders Nervous system Very common Uncommon Somnolence disorders Uncommon Very common Headache NR Uncommon Hypoesthesia NR Uncommon Dizziness NR Uncommon Syncope NR Uncommon Tremor Gastrointestinal Common Gastrointestinal symptoms (such as disorders nausea, diarrhoea, vomiting and abdominal pain) Skin and Uncommon Rash subcutaneous tissue NR Common Hyperhidrosis disorders NR Uncommon Skin Ulcer Musculoskeletal Uncommon Very common Myalgia and connective NR Uncommon Musculoskeletal stiffness tissue disorders NR Very common Arthralgia General disorders Very common Injection site pain and administration Common1 Fever (≥ 38.0 °C) site conditions Common Injection site redness Common Injection site swelling Uncommon Very common Fatigue Uncommon Common Chills Uncommon NR Injection site bruising Uncommon Injection site pruritus NR Uncommon Axillary pain 1 A higher frequency of fever occurred following dose 2 compared to dose 1 in each age group. NR=Not reported

Originalpassage; keine automatisch abgeleitete Schwere, Häufigkeit oder Kausalität. Auch verneinte Befunde und nicht untersuchte Kombinationen bleiben sichtbar.